|
JPS60235136A
(ja)
*
|
1984-05-09 |
1985-11-21 |
Kyodo Printing Co Ltd |
検版方法
|
|
US4709914A
(en)
*
|
1985-02-07 |
1987-12-01 |
Brandt, Inc. |
Electronic controller for dispensers and the like
|
|
GB8704269D0
(en)
*
|
1987-02-24 |
1987-04-01 |
Rue Systems De |
Monitoring system
|
|
JPH0614384B2
(ja)
*
|
1987-04-13 |
1994-02-23 |
ローレルバンクマシン株式会社 |
紙幣判別装置
|
|
US4958307A
(en)
*
|
1987-11-20 |
1990-09-18 |
Kabushiki Kaisha Toshiba |
Roll mark inspection apparatus
|
|
US4951223A
(en)
*
|
1989-03-28 |
1990-08-21 |
Langdon Wales R |
Web material inspection system
|
|
GB2284293B
(en)
*
|
1993-11-30 |
1998-06-03 |
Mars Inc |
Article classifying method and apparatus
|
|
US5807552A
(en)
*
|
1995-08-04 |
1998-09-15 |
Board Of Regents, The University Of Texas System |
Compositions for conferring immunogenicity to a substance and uses thereof
|
|
US6610838B1
(en)
|
1997-09-10 |
2003-08-26 |
Symbicom Aktiebolag |
P13 antigens from Borrelia
|
|
US6656471B1
(en)
*
|
1998-11-17 |
2003-12-02 |
Board Of Regents, The University Of Texas System |
HIV-specific T-cell induction
|
|
WO2001026357A1
(en)
*
|
1999-10-06 |
2001-04-12 |
Omron Corporation |
Recognition apparatus
|
|
KR100879810B1
(ko)
*
|
2000-02-21 |
2009-01-22 |
하. 룬드벡 아크티에셀스카브 |
아밀로이드의 하향-조절을 위한 신규한 방법
|
|
US20030086938A1
(en)
*
|
2000-02-21 |
2003-05-08 |
Jensen Martin Roland |
Novel methods for down-regulation of amyloid
|
|
US7097837B2
(en)
*
|
2001-02-19 |
2006-08-29 |
Pharmexa A/S |
Synthetic vaccine agents
|
|
EP1395605B8
(en)
|
2001-03-09 |
2014-12-17 |
Iterative Therapeutics, Inc. |
Polymeric immunoglobulin fusion proteins that target low-affinity fcgamma receptors
|
|
US8163289B2
(en)
*
|
2001-03-09 |
2012-04-24 |
Iterative Therapeutics, Inc. |
Methods and compositions involving polymeric immunoglobulin fusion proteins
|
|
US7547759B2
(en)
|
2001-03-09 |
2009-06-16 |
Board Of Regents, The University Of Texas System |
Induction of tumor immunity by variants of folate binding protein
|
|
SE0102327D0
(sv)
|
2001-06-28 |
2001-06-28 |
Active Biotech Ab |
A novel engineered superantigen for human therapy
|
|
MY144532A
(en)
*
|
2001-08-20 |
2011-09-30 |
Lundbeck & Co As H |
Novel method for down-regulation of amyloid
|
|
KR20040009725A
(ko)
*
|
2002-07-25 |
2004-01-31 |
삼성전자주식회사 |
화상형성장치의 용지공급장치 및 그 제어방법
|
|
WO2004058181A2
(en)
*
|
2002-12-20 |
2004-07-15 |
Board Of Regents, The University Of Texas System |
Vmp-like sequences of pathogenic borrelia species and strains
|
|
US6900449B2
(en)
*
|
2003-01-15 |
2005-05-31 |
Lexmark International Inc. |
Media type sensing method for an imaging apparatus
|
|
US20050002953A1
(en)
*
|
2003-05-06 |
2005-01-06 |
Jens Herold |
SARS-coronavirus virus-like particles and methods of use
|
|
MXPA05011965A
(es)
|
2003-05-09 |
2006-02-02 |
Pharmexa As |
Analogos inmunogenicos de tnf-alfa humano con citotoxicidad reducida y metodos para su preparacion.
|
|
CA2526690C
(en)
|
2003-05-23 |
2014-01-14 |
Board Of Regents The University Of Texas System |
Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors
|
|
US7316907B2
(en)
|
2003-09-10 |
2008-01-08 |
Board Of Regents, The University Of Texas System |
14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types
|
|
US7205561B2
(en)
*
|
2004-03-29 |
2007-04-17 |
Lexmark International, Inc. |
Media sensor apparatus using a two component media sensor for media absence detection
|
|
US7627938B2
(en)
*
|
2004-10-15 |
2009-12-08 |
Board Of Regents, The Univeristy Of Texas System |
Tapered hollow metallic microneedle array assembly and method of making and using the same
|
|
US8017385B2
(en)
*
|
2004-10-22 |
2011-09-13 |
Neurologix, Inc. |
Use of apotosis inhibiting compounds in degenerative neurological disorders
|
|
US20060210590A1
(en)
|
2005-02-03 |
2006-09-21 |
Alk-Abello A/S |
Minor allergen control to increase safety of immunotherapy
|
|
CN101253199B
(zh)
|
2005-08-30 |
2019-06-14 |
迈阿密大学 |
免疫调节肿瘤坏死因子受体25(tnfr25)的激动剂、拮抗剂和免疫毒素
|
|
ATE448247T1
(de)
|
2005-09-22 |
2009-11-15 |
Biocompatibles Uk Ltd |
Fusionspolypeptide vom glp-1 (glucagon-like peptide-1) mit erhöhten peptidaseresistenz
|
|
AU2007281934B2
(en)
|
2006-01-18 |
2012-11-15 |
University Of Chicago |
Compositions and methods related to Staphylococcal bacterium proteins
|
|
DE602006009631D1
(de)
|
2006-05-10 |
2009-11-19 |
Biocompatibles Uk Ltd |
GLP-1 Peptide enthaltende kugelförmige Mikrokapseln, deren Produktion und deren Verwendung
|
|
CN101500602A
(zh)
|
2006-08-01 |
2009-08-05 |
斯克里普斯研究院 |
控制肥胖症的疫苗及方法
|
|
US8097419B2
(en)
|
2006-09-12 |
2012-01-17 |
Longhorn Vaccines & Diagnostics Llc |
Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
|
|
US9481912B2
(en)
|
2006-09-12 |
2016-11-01 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
|
|
US8080645B2
(en)
|
2007-10-01 |
2011-12-20 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection/transport compositions and methods
|
|
US8652782B2
(en)
|
2006-09-12 |
2014-02-18 |
Longhorn Vaccines & Diagnostics, Llc |
Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
|
|
DE102007039485A1
(de)
*
|
2007-08-21 |
2009-02-26 |
Manroland Ag |
Verfahren zum Betreiben einer Rollendruckmaschine
|
|
US9683256B2
(en)
|
2007-10-01 |
2017-06-20 |
Longhorn Vaccines And Diagnostics, Llc |
Biological specimen collection and transport system
|
|
US11041215B2
(en)
|
2007-08-24 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
PCR ready compositions and methods for detecting and identifying nucleic acid sequences
|
|
CA2697373C
(en)
*
|
2007-08-27 |
2019-05-21 |
Longhorn Vaccines & Diagnostics, Llc |
Immunogenic compositions and methods
|
|
US10004799B2
(en)
|
2007-08-27 |
2018-06-26 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
|
US7923001B2
(en)
|
2007-09-07 |
2011-04-12 |
The Regents Of The University Of Michigan |
Compositions and methods for diagnosing and treating urinary tract infections
|
|
DK2535428T3
(en)
|
2007-10-01 |
2015-11-23 |
Longhorn Vaccines & Diagnostics Llc |
Biological prøvesamlings- and transport system, and methods of using
|
|
US11041216B2
(en)
|
2007-10-01 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
|
|
WO2009059328A2
(en)
*
|
2007-11-02 |
2009-05-07 |
The Johns Hopkins University |
Multi- component l2 vaccine for prevention of human papillomavirus infection
|
|
EP4071169A2
(en)
|
2008-08-25 |
2022-10-12 |
Dana Farber Cancer Institute, Inc. |
Conserved influenza hemagglutinin epitope and antibodies thereto
|
|
EP2163243A1
(en)
|
2008-09-12 |
2010-03-17 |
Biocompatibles UK Limited |
Treatment of acute myocardial infarction (AMI) using encapsulated cells encoding and secreting GLP-1 peptides or analogs thereof
|
|
CN102333540B
(zh)
|
2008-10-06 |
2015-04-22 |
芝加哥大学 |
与细菌eap、emp和/或adsa蛋白相关的组合物和方法
|
|
DK2406286T3
(en)
|
2009-03-10 |
2016-08-22 |
Baylor Res Inst |
Anti-cd40 antibodies and uses thereof
|
|
EP3219732A1
(en)
*
|
2009-03-10 |
2017-09-20 |
Baylor Research Institute |
Antigen presenting cell targeted cancer vaccines
|
|
CA2754764A1
(en)
|
2009-03-10 |
2010-09-16 |
Baylor Research Institute |
Antigen presenting cell targeted cancer vaccines
|
|
WO2011005341A2
(en)
|
2009-04-03 |
2011-01-13 |
University Of Chicago |
Compositions and methods related to protein a (spa) variants
|
|
EP2251028A1
(en)
|
2009-05-12 |
2010-11-17 |
Biocompatibles Uk Ltd. |
Treatment of eye diseases using encapsulated cells encoding and secreting an anti-angiogenic factor and/or a neuroprotective factor
|
|
NZ597458A
(en)
|
2009-07-03 |
2014-01-31 |
Bionor Immuno As |
Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means
|
|
US9849174B2
(en)
|
2009-11-20 |
2017-12-26 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions related to immunogenic fibrils
|
|
WO2011063264A1
(en)
|
2009-11-20 |
2011-05-26 |
University Of Chicago |
Methods and compositions related to immunogenic fibrils
|
|
GB0922209D0
(en)
|
2009-12-18 |
2010-02-03 |
Univ Nottingham |
Proteins, nucleic acid molecules and compositions
|
|
US9044606B2
(en)
|
2010-01-22 |
2015-06-02 |
Ethicon Endo-Surgery, Inc. |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
US8476227B2
(en)
|
2010-01-22 |
2013-07-02 |
Ethicon Endo-Surgery, Inc. |
Methods of activating a melanocortin-4 receptor pathway in obese subjects
|
|
WO2011100508A2
(en)
|
2010-02-12 |
2011-08-18 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
|
WO2011116262A2
(en)
*
|
2010-03-19 |
2011-09-22 |
The Regents Of The University Of Michigan |
Compositions and methods for diagnosing and treating urinary tract infections
|
|
US8808699B2
(en)
|
2010-04-05 |
2014-08-19 |
The University Of Chicago |
Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response
|
|
BR112013000097B1
(pt)
|
2010-07-02 |
2022-02-01 |
The University Of Chicago |
Polipeptídeo imunogênico isolado, composição imunogênica e seu uso
|
|
JP5793194B2
(ja)
|
2010-09-09 |
2015-10-14 |
ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ |
感染防御ブドウ球菌抗原が関与する方法および組成物
|
|
EP2616096A1
(en)
|
2010-09-15 |
2013-07-24 |
Biocompatibles Uk Ltd. |
Treatment of vascular diseases using encapsulated cells encoding and secreting glp-1, or a fragment or variant thereof
|
|
US9381219B2
(en)
|
2010-12-29 |
2016-07-05 |
Ethicon Endo-Surgery, Inc. |
Brown adipocyte modification
|
|
CA2831294A1
(en)
|
2011-03-25 |
2012-10-04 |
Baylor Research Institute |
Compositions and methods to immunize against hepatitis c virus
|
|
WO2012149525A2
(en)
|
2011-04-29 |
2012-11-01 |
Baylor College Of Medicine |
Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection
|
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
|
EP3494989B1
(en)
|
2012-01-26 |
2025-07-16 |
Longhorn Vaccines and Diagnostics, LLC |
Composite antigenic sequences and vaccines
|
|
US9968668B2
(en)
|
2012-04-26 |
2018-05-15 |
The University Of Chicago |
Staphylococcal coagulase antigens and methods of their use
|
|
HK1207829A1
(zh)
|
2012-06-06 |
2016-02-12 |
Bionor Immuno As |
疫苗
|
|
WO2015007337A1
(en)
|
2013-07-19 |
2015-01-22 |
Bionor Immuno As |
Method for the vaccination against hiv
|
|
EP3094652B1
(en)
|
2014-01-13 |
2021-09-29 |
Baylor Research Institute |
Novel vaccines against hpv and hpv-related diseases
|
|
EP3116540B1
(en)
|
2014-03-10 |
2022-08-17 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for treating, including preventing, parvovirus infections and related diseases
|
|
WO2016005508A1
(en)
|
2014-07-11 |
2016-01-14 |
Bionor Immuno As |
Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids)
|
|
US10080884B2
(en)
|
2014-12-29 |
2018-09-25 |
Ethicon Llc |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
US10092738B2
(en)
|
2014-12-29 |
2018-10-09 |
Ethicon Llc |
Methods and devices for inhibiting nerves when activating brown adipose tissue
|
|
WO2016177833A1
(en)
|
2015-05-04 |
2016-11-10 |
Bionor Immuno As |
Dosage regimen for hiv vaccine
|
|
EP3294448A4
(en)
|
2015-05-14 |
2018-12-12 |
Longhorn Vaccines and Diagnostics, LLC |
Rapid methods for the extraction of nucleic acids from biological samples
|
|
WO2017173398A1
(en)
|
2016-04-01 |
2017-10-05 |
Duke University |
Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
|
|
US10610585B2
(en)
|
2017-09-26 |
2020-04-07 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and compositions for treating and preventing HIV
|
|
WO2019183500A1
(en)
|
2018-03-23 |
2019-09-26 |
Hung Chiung Yu |
Coccidioides antigens and methods of their use
|
|
TW202327646A
(zh)
|
2021-10-15 |
2023-07-16 |
美商輝瑞大藥廠 |
Rna分子
|
|
JP2025503423A
(ja)
|
2021-12-17 |
2025-02-04 |
ファイザー・インク |
ポリヌクレオチド組成物およびその使用
|
|
WO2023144779A1
(en)
|
2022-01-28 |
2023-08-03 |
Pfizer Inc. |
Coronavirus antigen variants
|
|
WO2024089634A1
(en)
|
2022-10-27 |
2024-05-02 |
Pfizer Inc. |
Immunogenic compositions against influenza and rsv
|
|
PE20251592A1
(es)
|
2022-10-27 |
2025-06-16 |
Pfizer |
Moleculas de rna que codifican rsv-f y vacunas que las contienen
|
|
EP4630049A1
(en)
|
2022-12-11 |
2025-10-15 |
Pfizer Inc. |
Immunogenic compositions against influenza and rsv
|
|
WO2024154052A1
(en)
|
2023-01-16 |
2024-07-25 |
Pfizer Inc. |
Immunogenic compositions and methods of inducing an immune response against varicella zoster virus
|
|
WO2024256962A1
(en)
|
2023-06-14 |
2024-12-19 |
Pfizer Inc. |
Method for stabilizing rna
|
|
WO2025027492A1
(en)
|
2023-07-31 |
2025-02-06 |
Pfizer Inc. |
Coronavirus antigen variants
|
|
WO2025126019A1
(en)
|
2023-12-13 |
2025-06-19 |
Pfizer Inc. |
Rna molecules
|
|
WO2025126071A1
(en)
|
2023-12-14 |
2025-06-19 |
Pfizer Inc. |
Rna molecules
|
|
WO2025186719A1
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
WO2025186725A2
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Improved lnp formulations and uses thereof
|
|
WO2025202834A1
(en)
|
2024-03-26 |
2025-10-02 |
Pfizer Inc. |
Polynucleotide compositions and uses thereof
|